Anti-CLEC4C Antibody (BIIB059)
Catalog No.
F1677
Anti-CLEC4C Antibody (BIIB059)
Featured Products
Litifilimab is a humanized IgG1-κ antibody targeting C-type lectin domain family 4 member C (CLEC4C). Litifilimab is used in the research of cutaneous lupus erythematosus (CLE).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.6 kDa
Dry ice
2407378-48-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Litifilimab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q8WTT0
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized Ma CLEC4C His at 2 ug/mL can bind Anti-CLEC4C Antibody (BIIB059)
CLEC4C
Please avoid freeze-thaw cycles.